Table 2 Cost data and methodology
From: Cost of illness of breast cancer in low- and middle-income countries: a systematic review
Author | Year | Country | Cost data duration | Sensiti-vity analysis | Discount rate | Perspective | Cost method | Cost unit | Direct medical costs* | Direct non-medical costs* | Indirect costs* |
|---|---|---|---|---|---|---|---|---|---|---|---|
Pakseresht et al. [21] | 2011 | India | 6 months | None | None | Societal | Bottom-up | Cost per patient | 515 (0–3436) | 619 (0–3093) | NA |
Lan et al. [27] | 2013 | Vietnam | 5 years | Yes | 3% | Payer | Bottom-up | Annual cost per patient | 809 (SD 605) | NA | NA |
O’Neill et al. [20] | 2015 | Haiti | Treatment cycle | None | None | Societal | Bottom-up | Out-of-pocket cost per patient per treatment cycle | 195 (171–297) | 676 (502–974) | NA |
Shankar et al. [22] | 2018 | India | Treatment cycle | None | None | Payer | Mixed | Cost per patient per treatment cycle | 825 (172–858) | NA | NA |
Mahmood et al. [26] | 2018 | Pakistan | Treatment cycle | None | None | Payer | Mixed | Cost per patient per treatment cycle | 1534 (SD 1536) | 378 (SD 365) | 332 (SD 631) |
Afkar et al. [24] | 2020 | Iran | Treatment cycle | None | 3% | Payer | Bottom-up | Cost per patient per treatment cycle | 4808** | NA | NA |
Afkar et al. [23] | 2021 | Iran | One year (private hospital) | Yes | None | Societal | Bottom-up | Annual cost per patient in private hospital | 11,866 (SD 23,000) | 201 (SD 827) | 2208 (SD 5821) |
One year (public hospital) | as above | as above | as above | as above | Annual cost per patient in public hospital | 4676 (SD 8005) | 401 (SD 1063) | 26,390 (SD 21,997) | |||
Rezende et al. [17] | 2021 | Brazil | Annual cost | None | None | Payer | Top-down | Cost for country (2015–2017) (Brazil) | 377 million** | NA | NA |
Zheng et al. [18] | 2022 | China | Treatment cycle | None | None | Payer | Top-down | Annual BC cost for city (Dalian, China) | 78 million** | NA | NA |
Zhao et al. [19] | 2022 | China | Treatment | None | None | Payer | Top-down | Cost per patient per treatment | 952 (708–1303) | NA | NA |
Jalali et al. [25] | 2023 | Iran | Treatment cycle | None | None | Payer | Bottom-up | Cost per patient | 9060 (SD 6761) | 2233 (SD 2108) | 1525 (SD 3152) |
Umo et al. [28] | 2023 | Papua New Guinea | Treatment cycle | None | None | Payer | Bottom-up | Cost per patient | 7248** | NA | NA |